Man Group PLC Sight Sciences, Inc. Transaction History

Man Group PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$8.44 - $13.35 $106,133 - $167,876	-12,575 Reduced 46.23%	14,625 $127,000
Q4 2022 Feb 14, 2023	SELL	$5.58 - $13.94 $45,142 - $112,774	-8,090 Reduced 22.92%	27,200 $332,000
Q3 2022 Nov 14, 2022	BUY	$6.1 - $11.41 $4,819 - $9,013	790 Added 2.29%	35,290 $224,000
Q2 2022 Aug 15, 2022	SELL	$6.61 - $11.99 $141,275 - $256,262	-21,373 Reduced 38.25%	34,500 $310,000
Q1 2022 May 16, 2022	BUY	$11.56 - $17.9 $472,399 - $731,483	40,865 Added 272.29%	55,873 $646,000

Q4 2021 Feb 14, 2022	SELL	$17.36 - $27.36 $19,096 - $30,096	-1,100 Reduced 6.83%	15,008 $264,000
Q3 2021 Nov 15, 2021	BUY	$22.34 - $39.1 $359,852 - $629,822	16,108 New	16,108 $366,000

21.1M

33.2K

27.7K

Ticker SGHT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,826,200
Market Cap $296M
Description
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.